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The maintenance of cellular homeostasis is largely dependent on the ability of cells to give an adequate response to various internal
and external stimuli. We have recently proposed that the life-and-death decision in endoplasmic reticulum (ER) stress response is
deﬁned by a crosstalk between autophagy, apoptosis, and mTOR-AMPK pathways, where the transient switch from autophagy-
dependent survival to apoptotic cell death is controlled by GADD34. The aim of the present study was to investigate the role of
epigallocatechin-3-gallate (EGCG), the major polyphenol of green tea, in promoting autophagy-dependent survival and to verify
the key role in connecting GADD34 with mTOR-AMPK pathways upon prolonged ER stress. Our ﬁndings, obtained by
using HEK293T cells, revealed that EGCG treatment is able to extend cell viability by inducing autophagy. We conﬁrmed
that EGCG-induced autophagy is mTOR-dependent and PKA-independent; furthermore, it also required ULK1. We show
that pretreatment of cells with EGCG diminishes the negative eﬀect of GADD34 inhibition (by guanabenz or siGADD34
treatment) on autophagy. EGCG was able to delay apoptotic cell death by upregulating autophagy-dependent survival even
in the absence of GADD34. Our data suggest a novel role for EGCG in promoting cell survival via shifting the balance of
mTOR-AMPK pathways in ER stress.
1. Introduction
Green tea is a type of traditional Chinese tea made from
Camellia sinensis leaves, and it has been demonstrated to
possess profound biochemical and pharmacological activi-
ties, including antioxidative, anti-inﬂammatory, and anti-
carcinogenic properties [1–3]. Green tea contains several
polyphenolic components, for example, catechin, epicate-
chin, and epigallocatechin-3-gallate (EGCG). Eﬀects of the
most abundant green tea polyphenol EGCG have been
shown in various pathophysiological conditions, including
insulin resistance, endothelial dysfunction, and ischemia-
reperfusion injuries [4–6]. Many scientiﬁc reports proposed
that green tea is able to inﬂuence several biological processes
by inhibiting telomerase, mitogen-activated protein kinase
(MAPK), activator protein-1, or nuclear factor- (NF-) κB
[7]. It has been also shown that EGCG is able to extend
longevity signiﬁcantly under several stress conditions by
postponing aging and age-related diseases [8–10].
Cellular homeostasis is ﬁnely controlled by an evolu-
tionarily conserved cytoprotective cellular digestive process,
called autophagy [11]. Cells have residual autophagic activity
even under physiological conditions; however, the process
gets more eﬃcient during various stress events (i.e., starva-
tion and growth factor deprivation) [12]. During autophagy,
cellular components become sequestered into a double-
membrane vesicle, whose contents are then delivered to and
degraded by lysosomes [13, 14]. Due to the crucial role of
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autophagy in maintaining cellular homeostasis, this self-
eating process is precisely regulated [11]. Interestingly, an
excessive level of autophagy is also known to cause cell
death [15].
One of the key roles of autophagy is to maintain essential
cellular activity and viability under limited nutrient avail-
ability [13]. Therefore, autophagy is tightly controlled by
the two sensors of nutritional conditions, called mTOR and
AMPK [16–18]. mTOR (mammalian target of rapamycin)
is a serine/threonine protein kinase in the mTORC1 com-
plex, which is the main component of the mTOR pathway
[18, 19]. This complex is a master regulator by integrating
inputs from external and internal signals, such as growth
factors, amino acids, glucose, and energy status, to control
growth and metabolism [20]. Besides mTOR, AMPK (AMP-
activated protein kinase) also senses cellular energy status
and has a crucial role in maintaining energy homeostasis
[21]. AMPK tightly controls ATP-consuming processes,
such as glycogen or protein syntheses, and it upregulates
processes that yield ATP (i.e., glycolysis) [22, 23]. AMPK
is able to promote self-eating by phosphorylating ULK1,
one of the main inducers of autophagosome formation
[17, 21]. However, ULK1 is also regulated by an mTOR-
dependent inhibitory phosphorylation under nutrient-rich
condition [21]. In addition, AMPK directly inhibits mTORC1
complex via phosphorylation [17, 21] indicating that a
proper balance of AMPK-mTOR pathways is essential at
physiological conditions.
It has been lately suggested that EGCG might induce
a cytoprotective autophagy in various stress events. Treat-
ment with EGCG promotes the formation of autophago-
somes both in primary bovine endothelial and human
hepatoma (HepG2) cells [24, 25]. EGCG abolishes the
palmitate-induced accumulation of lipid droplets via facili-
tated autophagic ﬂux [24]. Autophagy enhancement upon
EGCG administration is unfavourable for hepatitis B virus
replication, and hence it is considered as a potential thera-
peutic strategy [25]. EGCG also has neuroprotective eﬀect
by activating autophagy and inhibiting Bax and cyto-
chrome c translocation in prion-protein-induced damages
[26]. Although the positive role of EGCG in enhancing
autophagy at various diseases has been already suggested,
details of the regulatory mechanisms induced by this natural
compound are yet to be revealed.
Huang et al. have suggested that EGCG upregulates
AMPK activity in a dose-dependent manner, while mTOR
pathway gets inhibited in hepatoma cells [27]. A docking
experiment has also shown that EGCG is an ATP-
competitive inhibitor of mTOR [28]. Kim et al. suggested
that EGCG enhances autophagy through an AMPK-
mediated mechanism [24]. Interestingly, EGCG stimulated
both AMPK and ULK1, but not mTOR, indicating that the
polyphenol-induced autophagy is independent from mTOR
pathway [24]. These results suggest that EGCG acts as an
enhancer on AMPK; however, its eﬀect on mTOR pathway
is still contradictory.
Recently, we have conﬁrmed that activation of autophagy
has a cytoprotective role upon high level of endoplasmic
reticulum (ER) stress [29, 30]. This transient elevation of
autophagy is characterized by downregulation of mTOR
and upregulation of AMPK. Therefore, mTOR inhibitors
and/or AMPK activators (such as rapamycin, resveratrol,
and metyrapone) are able to postpone apoptotic cell death
during excessive ER stress [29, 31]. EGCG is able to restore
Ca2+ homeostasis suggesting its cytoprotective eﬀect in ER
stress [32]; however, the detailed mechanism of the EGCG-
modulated ER stress response remains to be elucidated.
In this study, we investigate the mechanism of EGCG-
dependent autophagy and its role in ER stress by using a
human cell line. We propose that the cytoprotective autoph-
agy stimulated by EGCG is regulated via both mTOR and
ULK1. We also show that EGCG-induced self-eating process
is independent from PKA. Here, we present that EGCG
aﬀects the balance of mTOR-AMPK, which delays apoptotic
cell death by upregulating autophagy upon ER stress. Our
data demonstrate a novel mechanism underlying the eﬀect
of EGCG on life-and-death decision in ER stress.
2. Materials and Methods
2.1. Materials. Thapsigargin (Sigma-Aldrich, T9033), tunica-
mycin (Sigma-Aldrich, T7765), rapamycin (Sigma-Aldrich,
R0395), guanabenz (Sigma-Aldrich, G110), H89 (Adipo-
gen, AG-CR1-0002), and epigallocatechin gallate (Sigma-
Aldrich, E4143) were purchased. All other chemicals were
of reagent grade.
2.2. Cell Culture and Maintenance. A human embryonic
kidney cell line (HEK293T, ATCC, and CRL-3216) was used
as a model system. It was maintained in DMEM (Life Tech-
nologies, 41965039) medium supplemented with 10% fetal
bovine serum (Life Technologies, 10500064) and 1% antibi-
otics/antimycotics (Life Technologies, 15240062). Culture
dishes and cell treatment plates were kept in a humidiﬁed
incubator at 37°C in 95% air and 5% CO2.
2.3. SDS-PAGE and Western Blot Analysis. Cells were
harvested and lysed with 20mM Tris, 135mM NaCl, 10%
glycerol, and 1% NP40, pH6.8. Protein content of cell lysates
was measured using Pierce BCA Protein Assay (Thermo Sci-
entiﬁc, 23225), and equal amounts of proteins were used in
the analysis. SDS-PAGE was done by using Hoefer miniVE
(Amersham). Proteins were transferred onto Millipore
0.45μM PVDF membrane. Immunoblotting was performed
using TBS Tween (0.1%), containing 5% nonfat dry milk,
1% bovine serum albumin (Sigma-Aldrich, A9647), or gela-
tin buﬀer (Sigma-Aldrich, G8327) for blocking membrane
and for antibody solutions. Loading was controlled by
developing membranes for GAPDH or by dying them with
Ponceau S in all experiments. At least three independent
measurements were carried out in each experiment. The
following antibodies were applied: antiLC3B (SantaCruz,
sc-16755), antiCaspase3 (SantaCruz, sc-7272), antiPARP
(Cell Signaling, 9542S), antiULK-555-P (Cell Signaling,
5869S), antiULK (Cell Signaling, 8054S), antip70S6-P (Cell
Signaling, 9234S), antip70S6 (SantaCruz, sc-9202), anti4-
EBP1-P (Cell Signaling, 9459S), anti4-EBP1 (Cell Signaling,
9644S), antiGADD34 (SantaCruz, sc-8327), antieiF2α-P
2 Oxidative Medicine and Cellular Longevity
(Cell Signaling, 9721S), antieiF2α (Cell Signaling, 9722S),
antiAMPK-P (Cell Signaling, 2531S), antiAMPK (Cell
Signaling, 2603S) and antiGAPDH (Santa Cruz, 6C5), and
HRP-conjugated secondary antibodies (SantaCruz, sc-2354
and Cell Signaling, 7074S and 7076S). The bands were
visualised using chemiluminescence detection kit (Thermo
Scientiﬁc, 32106).
2.4. RNA Interference. RNA interference experiments were
performed using Lipofectamine RNAi Max (Invitrogen)
in GIBCO™ Opti-MEM I (GlutaMAX™-I) reduced-serum
medium liquid (Invitrogen) and 20pmol/ml siRNA. The
siGADD34 oligonucleotides were purchased from Ther-
moFisher (HSS177543), and the siULK oligonucleotides
were purchased fromAmbion (AM16708). 200000HEK293T
cells were incubated at 37°C in a CO2 incubator in
antiobiotic-free medium for 16 hours, and then the RNAi
duplex-Lipofectamine™ RNAiMAX (Invitrogen, 13778-075)
complexes were added to the cells for overnight. Then
fresh medium was added to the cells, and the appropriate
treatment was carried out. To check the eﬃciency of
GADD34 silencing, Western blot was used with GADD34
monoclonal antibody (SantaCruz, sc-373815).
2.5. RNA Extraction and Real-Time PCR. Total RNA content
of cells was extracted using TRIzol RNA isolation reagent
(Invitrogen) [33]. Retrotranscription was performed using
SuperScriptII First-Strand Synthesis System (Invitrogen).
Nucleic acid levels were measured using GenQuant pro
RNA/DNA calculator. Equal amounts of cDNA were used
for real-time PCR to check the eﬃciency of GADD34 silenc-
ing. PCR reaction and real-time detection were performed
using GoTaq(R) qPCR Master Mix (Promega, A6002) and
STRATAGENEMx3005P Real-Time PCR Detection System.
The real-time PCR thermocycles were the following: 95°C
10min (1x), 95°C 30 sec, 58°C 45 sec, 72°C 30 sec (40x),
95°C 5min, 55°C 1min, and 97°C 30 sec (1x). The appropri-
ate forward and reverse real-time PCR primers were used for
GADD34 and GAPDH.
2.6. Cell Viability Assays. The relative amount of viable cells
was calculated by Burker chambers. Cell viability was
detected using CellTiter-Blue assay (Promega, G8080). Cells
were grown and treated on 96-well plates and were incubated
with resazurin for 2 h at 37°C. Absorbance was measured at
620nm and expressed in arbitrary unit, being proportional
to cell toxicity. At least three parallel measurements were
carried out for each of these experiments.
2.7. Statistics. For densitometry analysis, Western blot data
were acquired using ImageJ software. The relative band
densities were shown and normalized to an appropriate total
protein or GAPDH band used as reference protein (see
Supplementary Information available here). For each of the
experiments, three independent measurements were car-
ried out. Results are presented as mean values± S.D.
and were compared using ANOVA with Tukey’s multi-
ple comparison post hoc test. Asterisks indicate statisti-
cally signiﬁcant diﬀerence from the appropriate control:
∗p < 0 05; ∗∗p < 0 01.
3. Results
3.1. EGCG Aﬀects Autophagy and Apoptosis in a Dose-
Dependent Manner. The beneﬁcial health eﬀect of EGCG
has been widely studied. It has been shown that low concen-
trations of EGCG enhance viability of HepG2 cells; however,
its high concentration causes a signiﬁcant decrease in the
number of viable cells [34]. Experimental data have also
revealed that EGCG is able to enhance both autophagy and
apoptosis [35]. In order to ﬁgure out whether these cellular
processes are correlated to cell viability during EGCG treat-
ment, we further explored the role of green tea polyphenol
in cellular decision-making process between life and death.
First, human embryonic kidney cells (HEK293T) were
treated with various concentrations (10, 20, 40, and 80μM)
of EGCG for 24 h, and we monitored both the relative
number of viable cells and cell viability (Figure 1(a)). Corre-
sponding to the already published data, we could conﬁrm
that low concentrations of EGCG (i.e., 10 and 20μM)
resulted in a slight increase in cell viability, while excessive
level of the polyphenol (i.e., 80μM) reduced the amount of
viable cells by ≈50%.
To detect the activation proﬁle or level of the key indica-
tors of autophagy (such as LC3II and ULK-555-P) and
apoptosis (procaspase-3, cleaved PARP) during EGCG treat-
ment, immunoblotting was performed (Figures 1(b) and S1).
At low concentration of EGCG (i.e., 10 and 20μM), a high
ratio of LC3II/LC3I and an intensive phosphorylation of
ULK-555-P were observed indicating that cell viability is
maintained in an autophagy-dependent manner by EGCG
in a well-deﬁned concentration range. However, a high
concentration of EGCG (80μM) slightly decreased the activ-
ity of autophagy, which was accompanied by a decrease in
procaspase-3. Active capase-3 is able to cleave PARP; how-
ever, we did not observe any PARP cleavage suggesting that
EGCG-dependent apoptosis might occur at a higher concen-
tration of the polyphenol. Interestingly, ER stress was already
observed at low concentration of EGCG (see eiF2α-P and
GADD34 level in Figures 1(b) and S1), although the amount
of phosphorylated eiF2α was reduced at an excessive level of
this natural compound.
It is well-known that EGCG enhances AMPK, but its
negative eﬀect on mTOR has not been thoroughly studied
yet. To investigate the role of EGCG in modifying the
cellular balance of AMPK-mTOR pathways, we detected
the key markers of AMPK (AMPK-P, ULK-555-P) and
mTOR pathways (such as 4-EBP1-P and p70S6-P) by
immunoblotting (Figures 1(b) and S1). EGCG treatment
signiﬁcantly enhances AMPK (see the phosphorylated sta-
tus of both AMPK and ULK in Figures 1(b) and S1)
while mTOR became inactivated. This was detected by
both the dephosphorylation of p70S6 and the appear-
ance of the lowest phosphorylation band of 4-EBP1
(Figures 1(b) and S1).
Taken together, these results further conﬁrm that EGCG-
induced autophagy is not hazardous for human cells but
rather helps maintain cell viability; however, excessive level
of this polyphenol might promote an apoptotic cell death.
Low dose of EGCG is suﬃcient to activate AMPK and inhibit
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mTOR suggesting that EGCG has a key role in unbalancing
AMPK-mTOR pathways.
3.2. EGCG Induces Autophagy through mTOR-AMPK
Pathways. To further explore that EGCG-induced autoph-
agy via unbalancing AMPK-mTOR pathways, we used
various drugs to enhance autophagy. It is well known
that rapamycin (Rap) treatment induces autophagy via
mTOR downregulation [19], while H-89 is a PKA inhib-
itor and promotes an mTOR-independent autophagy [36]
(Figure S2). In order to understand EGCG-induced
autophagy, we treated HEK293T cells with either Rap
(100 nM, 2 h) or H-89 (2.5μM, 2h) and EGCG (20μM,
24h) without/with a subsequent Rap (100 nM, 2 h) or H-89
(2.5μM, 2h) addition.
We found that combined treatments (i.e., H-89 +EGCG
and Rap+EGCG) did not cause a remarkable decrease in
either cell viability or the relative amount of viable cells
(Figure S3). Next, the key markers of autophagy, AMPK
and mTOR pathways, were detected by immunoblotting
(Figure 2). The Rap+EGCG treatment did not cause any
additive eﬀect on autophagy induction, AMPK activation,
and mTOR downregulation, suggesting that both EGCG
and Rap act via the same pathway to induce autophagy.
Interestingly, the combined treatment with EGCG and
H-89 had a signiﬁcant additive eﬀect on autophagy induc-
tion, indicating that EGCG and H-89 employ diﬀerent path-
ways to promote autophagy. Although H-89 itself did not
modify the balance of AMPK-mTOR pathways, EGCG was
able to activate AMPK (see the phosphorylation of AMPK
in Figure 2) and downregulate mTOR (see 4-EBP1-P in
Figure 2) in the combined treatment.
Our combinatory treatment experiments suggest that
EGCG does not activate autophagy in a PKA-dependent
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Figure 1: EGCG induces autophagy in a concentration-dependent manner. HEK293T cells were treated with 10, 20, 40, and 80μMEGCG for
24 h. (a) Meanwhile, the relative number of viable cells (upper panel) and relative cell viability (lower panel) were denoted. (b) During EGCG
treatment, the markers of autophagy (LC3, ULK-555-P), apoptosis (procaspase-3, PARP), AMPK (AMPK-P), and mTOR (4-EBP1-P,
p70S6-P), as well as ER stress markers (i.e., eiF2α-P and GADD34) were followed by immunoblotting. GAPDH was used as loading
control. For each of the experiments, three independent measurements were carried out. Error bars represent standard deviation, and
asterisks indicate statistically signiﬁcant diﬀerence from the control: ∗p < 0 05.
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manner. Similarly to Rap, EGCG rather induces autophagy
via unbalancing AMPK-mTOR pathways.
3.3. ULK1 Is Essential for the EGCG-Induced Autophagy. It is
well-known that both AMPK and mTOR regulate autophagy
through the phosphorylation of ULK1, one of the key control
elements of this cellular process [21]. While AMPK stimu-
lates ULK1 via phosphorylating its Ser-555 and Ser-777,
mTOR inhibits autophagy by phosphorylation of diﬀerent
Ser residues in ULK1 (i.e., Ser-757) [21]. Therefore, to further
conﬁrm the role of AMPK-mTOR pathways in EGCG-
induced autophagy, the eﬀect of EGCG- (20μM, 24h)
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Figure 2: mTOR pathway is essential for EGCG-dependent autophagy induction. HEK293T cells were treated with rapamycin
(Rap—100 nM, 2 h), H-89 (2.5 μM, 2 h), and EGCG (20 μM, 24 h) without/with followed by Rap (100 nM, 2 h) or H-89 (2.5 μM, 2 h)
addition. (a) The markers of autophagy (LC3), apoptosis (procaspase-3, PARP), AMPK (AMPK-P), and mTOR (4-EBP1-P) were followed
by immunoblotting. GAPDH was used as loading control. (b) Densitometry data represent the intensity of procaspase-3, cleaved PARP
normalized for GAPDH, LC3II normalized for LC3I, AMPK-P normalized for total level of AMPK, and 4-EBP1-P normalized for total
level of 4-EBP1. For each of the experiments, three independent measurements were carried out. Error bars represent standard deviation,
and asterisks indicate statistically signiﬁcant diﬀerence from the control: ∗∗p < 0 01.
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induced autophagy was detected in the presence or absence
of ULK1 (Figure 3). We carried out Rap (100 nM, 2 h)
and H-89 (2.5μM, 2h) treatments for controls. ULK1
knockdown using siULK did not aﬀect the relative amount
of viable cells suggesting that ULK depletion did not
induce cell death (Figure 3(a)).
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Figure 3: ULK1 is essential for EGCG-dependent autophagy induction. HEK293T cells were treated with rapamycin (Rap—100 nM, 2 h),
H-89 (2.5 μM, 2 h), and EGCG (20 μM, 24 h) without/with followed by Rap (100 nM, 2 h) or H-89 (2.5μM, 2 h) addition. (a) Meanwhile,
the relative number of viable cells was denoted. (b) The markers of autophagy (LC3, ULK-555-P) and apoptosis (procaspase-3, PARP)
were followed by immunoblotting. GAPDH was used as loading control. (c) Densitometry data represent the intensity of procaspase-3,
cleaved PARP, and ULK-555-P and total level of ULK1 normalized for GAPDH, LC3II normalized for LC3I, and ULK-555-P
normalized for total level of ULK. For each of the experiments, three independent measurements were carried out. Error bars represent
standard deviation, and asterisks indicate statistically signiﬁcant diﬀerence from the control: ∗p < 0 05; ∗∗p < 0 01.
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Depletion of ULK1 abolished EGCG-induced autoph-
agy (see the low LC3II/I ratio in Figures 3(b) and 3(c)).
Similarly to EGCG, Rap was not able to promote autoph-
agy in the absence of ULK1, while siULK did not aﬀect
the H-89-induced autophagy (see the LC3II/I ratios in
Figures 3(b) and 3(c)). These results further conﬁrm that
AMPK-mTOR-regulated autophagy is independent from
the PKA pathway.
Taken together, we could conclude that ULK1 is involved
in EGCG-induced autophagy and in shifting the balance of
mTOR-AMPK pathways.
3.4. EGCG Delays Apoptotic Cell Death at an Excessive Level
of ER Stress. We have recently identiﬁed various drugs (such
as metyrapone and resveratrol), which imbalance mTOR-
AMPK pathways and thus induce autophagy-dependent
survival in ER stress [31, 37]. Since EGCG aﬀects the activa-
tion of AMPK and mTOR, we examined whether EGCG also
has a positive eﬀect on cell survival during ER stress.
In order to verify the role of EGCG in ER stress,
HEK293T cells were pretreated with EGCG (20μM, 24h)
and then an ER stressor was added, such as thapsigargin
(10μM, 2h) or tunicamycin (25μM, 2h). While thapsigargin
(TG) disrupts the calcium storage of the ER, tunicamycin
(TM) inhibits N-linked glycosylation of secretory and
membrane proteins in the ER [38, 39]. We have already
shown that TM- or TG-induced ER stress occurs a tran-
sient peak of autophagy-dependent survival followed by
apoptotic cell death [29]. To explore whether EGCG is
capable to maintain cell viability upon ER stress, both
the relative amount of viable cells and relative cell via-
bility were detected during EGCG+TG or EGCG+TM
treatments (Figures 4(a) and 5(a)). Addition of EGCG
prior to TG or TM signiﬁcantly extended cell viability
and postponed cell death even at continuous treatments
with an excessive level of the ER stressor. Our result
suggests that this polyphenol is capable of improving
cell viability.
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Figure 4: EGCG pretreatment extends autophagy-dependent survival with respect to TG-induced ER stress. HEK293T cells were pretreated
with 20μM EGCG for 24 h followed by TG (10 μM) treatment for 2 h. (a) Meanwhile, the relative number of viable cells (upper panel) and
relative cell viability (lower panel) were denoted in time. (b) The markers of autophagy (LC3, ULK-555-P), apoptosis (procaspase-3, PARP),
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represent standard deviation, and asterisks indicate statistically signiﬁcant diﬀerence from the control: ∗p < 0 05; ∗∗p < 0 01.
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In order to detect the eﬀect of EGCG with respect to ER
stress, autophagy, apoptosis, AMPK, and mTOR markers
were followed during EGCG+TG or EGCG+TM treatments
in time by immunoblotting (Figures 4(b), 5(b), S4, and S5). A
remarkably high level of LC3II/I suggested that autophagy
remained active even after a two-hour-long TG or TM treat-
ment, while neither a drop in procaspase-3 nor the cleavage
of PARP was observed. These results indicate that EGCG
is able to postpone apoptotic cell death via autophagy
induction upon an excessive level of ER stress.
The intensive phosphorylation of both AMPK and ULK
(on its Ser-555 residue) suggests that AMPK got stimulated
and remained active until the end of the combined treatment
(Figures 4(b), 5(b), S4, and S5). The mTOR pathway got
downregulated when ER stress was preceded with EGCG
addition (see the 4-EBP1-P in Figures 4(b), 5(b), S4, and S5).
These results indicate that EGCG induces autophagy via
unbalancing mTOR-AMPK pathways, and by this means it
delays apoptotic cell death in ER stress.
3.5. Addition of EGCG Can Rescue GADD34 Inhibition with
Respect to ER Stress. Recently, we have suggested that one
of the key elements of ER stress response mechanism, called
GADD34 (the growth arrest and DNA damage-inducible
protein) associated with PP1 (protein phosphatase 1), con-
stitutes a mechanistic link between ER stress and mTOR
activation [37]. It has been also suggested that GADD34
promotes autophagy-dependent survival via downregulat-
ing mTOR in ER stress or in the stress caused by the
expression of mutant huntingtin proteins [37, 40]. Inhibi-
tion of GADD34 by a PP1 inhibitor (i.e., guanabenz) or
transfection with siGADD34 results in a downregulation
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Figure 5: EGCG pretreatment extends autophagy-dependent survival with respect to TM-induced ER stress. HEK293T cells were treated
with 20μM EGCG for 24 h followed by TM (25 μM) treatment for 2 h. (a) Meanwhile, the relative number of viable cells (upper panel)
and relative cell viability (lower panel) were denoted in time. (b) The markers of autophagy (LC3, ULK-555-P), apoptosis (procaspase-3,
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of autophagy-dependent survival and a quick activation of
mTOR pathway, followed by apoptotic cell death during
ER stress [37]. Both rapamycin and resveratrol treatments
are able to diminish the negative eﬀect of GADD34 down-
regulation by promoting autophagy induction, AMPK
upregulation, and mTOR inhibition [37]. Since EGCG seems
to be a potential regulator of mTOR-AMPK balance upon
cellular stress, the polyphenol might protect the cells via
autophagy induction even in the absence of GADD34 under
ER stress.
GADD34 protein level got activated quickly when ER
stress was preceded by EGCG addition (Figures 4(b), 5(b),
S4, and S5). We observed that GADD34 level remained high
even after 2 h long treatment with TM or TG supposing its
important role in EGCG-induced autophagy with respect to
ER stress.
To explore whether EGCG pretreatment can rescue
GADD34 downregulation-induced apoptotic cell death upon
ER stress, we carried out a combined treatment. First,
HEK293T cells were treated with a GADD34 inhibitor,
called guanabenz (GB—5μM, 1h), followed by EGCG
addition (20μM) for 24 h. Then ER stress was induced
by TG (10μM, 2h) or TM (25μM, 2h). EGCG pretreat-
ment was able to extend cell viability and increase the
relative amount of viable cells in GB-pretreated cells under
ER stress (Figure S6).
We analysed the eﬀect of GADD34 inhibition during ER
stress combined with/without EGCG addition via detecting
autophagy, apoptosis, AMPK, and mTORmarkers by immu-
noblotting (Figures 6 and 7). The inactivation of GADD34
was detected by eiF2α-P. In the absence of EGCG, GB quickly
downregulates autophagy and induces apoptotic cell death
during ER stress. However, when cells were pretreated with
EGCG, the high ratio of LC3II/I indicates an intensive
autophagy until the end of the treatment; meanwhile,
apoptosis remains inactive. Neither procaspase-3 depletion
nor PARP cleavage was detected in the presence of EGCG.
Interestingly, EGCG was able to induce AMPK (see the
intensive phosphorylation of both AMPK and ULK1 in
Figures 6 and 7) and downregulate mTOR (see 4-EBP1-P
in Figures 6 and 7) even if GADD34 was inhibited by GB
during ER stress.
These data suggest that EGCG is able to maintain cell
viability via autophagy-dependent survival even in the
absence of GADD34 upon ER stress. Our experiments
indicate that the negative eﬀect of GADD34 inhibition by
GB can be suppressed by EGCG-induced imbalance of
mTOR-AMPK pathways with respect to ER stress.
3.6. GADD34 Silencing by siRNA Has Similar Eﬀects to
GB Treatment with Respect to ER Stress. To conﬁrm that
EGCG postpones ER stress-induced apoptotic cell death
via GADD34, the combined treatment of ER stressor and
EGCG was done in cells where GADD34 was silenced with
siRNA (Figures 8 and S7). First, we tested the eﬃciency of
siGADD34 both on mRNA (data not shown) and protein
(Figure S7A) levels. Similar to addition of GB, GADD34
silencing drastically decreased the amount of viable cells
during TG treatment, while pretreatment with 20μM EGCG
for 24 h was able to maintain cell viability (Figure S7B). Addi-
tion of TG in HEK293T cells expressing siGADD34 resulted
in a short and dumped autophagic response (see the weak
LC3II/I ratio and ULK1 phosphorylation in Figure 8), while
an early apoptosis induction was observed, that is, depletion
of procaspase-3 and appearance of cleaved PARP were
already detected after 1.5 h long TG treatment. By contrast,
EGCG pretreatment could maintain autophagy-dependent
survival and delay apoptotic cell death even in the absence
of GADD34 (Figure 8). Both LC3II/LC3I and ULK-555-P
levels remain high; meanwhile, no caspase-3 activation was
noticed. In these combined treatments, the AMPK also
maintained its active state (see the constant phosphorylation
of both AMPK and ULK1 in Figure 8), while the mTOR
pathway remained blocked (see 4-EBP1-P in Figure 8).
Similar eﬀects were observed by using TM (data not shown).
These data further conﬁrm that the negative eﬀect of
GADD34 silencing during ER stress can be rescued by
EGCG addition. This natural compound is able to imbal-
ance the AMPK-mTOR pathways and promote autophagy-
dependent survival in the absence of GADD34.
4. Discussion
ER has a key function to maintain cellular homeostasis by
containing some of the main regulatory elements of life-
and-death decision. Consequently, ER stress-induced dam-
ages appear in lots of diﬀerent human pathologies such as
neurodegenerative diseases, obesity, type two diabetes, and
many others [41–43]. Using both molecular and theoretical
biological techniques, we have shown previously that apopto-
tic cell death is always preceded by autophagy-dependent
survival upon excessive level of ER stress [29, 31]. Therefore,
newly identiﬁed autophagy inducers might become potent
drugs in the future by postponing the injurious eﬀects of
ER stress. We have recently conﬁrmed that the “survival
window” of autophagy can be expanded by pretreatment
with mTOR inhibitors and/or AMPK activators (such as
metyrapone and resveratrol) upon ER stress [31, 37]. Here,
we introduce a new candidate for extending cell viability,
namely, epigallocatechin-3-gallate (EGCG). Plant polyphe-
nols, including green tea ﬂavanols, have pleiotropic eﬀects;
however, many of their speciﬁc molecular targets have been
recently identiﬁed. Flavanols are widely known as antioxi-
dants, but under certain conditions (e.g., in the presence of
ferric iron) behave as prooxidants [44]. Since they act mainly
on cellular membranes, green tea ﬂavanols are known to
modulate various functions of the ER [45], including
luminal enzyme activities [46, 47], membrane transport
processes [48, 49], and redox homeostasis [47]. It has been
also demonstrated that EGCG extends life expectancies
signiﬁcantly, which was attributed either to decreased
oxidative stress and inﬂammation [10] or to the induced
production of reactive oxygen species [50]. However, the
involvement of the AMPK/SIRT1/FOXO axis seems to be
ﬁrmly established.
Our data demonstrate that a low concentration of EGCG
is able to induce autophagy (Figures 1(b) and S1) con-
comitantly with rise in cell viability, suggesting this
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activation of self-eating process induced by the polyphe-
nol is not harmful for the cells (Figure 1(a)). Pretreat-
ment with low concentration of EGCG followed by
addition of ER stressor (TG or TM) could extend
autophagy-dependent survival (Figures 4(b), 5(b), S4, and
S5); meanwhile, cell viability did not change (Figures 4(a)
and 5(a)) and apoptosis (e.g., PARP cleavage) was not
observed upon ER stress (Figures 4(b), 5(b), S4, and S5).
Interestingly, Ahn et al. have indicated that the cytotoxic
eﬀect of excessive level of EGCG is due to the expression of
ER stress response proteins, such as CHOP, GADD34, and
ATF3 [34]. Here, we show that the translational initiation
factor, eiF2α, gets phosphorylated even at low level of EGCG
(Figures 1(b) and S1). Although eiF2α-P has a key role in
shutting down the global protein translation upon ER stress,
no cell death is observed suggesting that activation of ER
stress response mechanism is not fatal. Rather this eiF2α
phosphorylation induced by EGCG is essential to upregulate
GADD34 level. In this study, we assume that GADD34 level
is increased parallel to autophagy induction upon EGCG
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Figure 6: EGCG-dependent eﬀect on mTOR-AMPK pathways rescues GADD34 inhibition with respect to TG-induced ER stress. HEK293T
cells were pretreated with GB (5 μM, 1 h) then without/with EGCG (20 μM, 24 h) followed by TG addition (10 μM, 2 h). The GB level was kept
high until the end of the cell treatment. (a) After TG treatment, the markers of autophagy (LC3, ULK-555-P), apoptosis (procaspase-3,
PARP), AMPK (AMPK-P), and mTOR (4-EBP1-P), as well as ER stress markers (eiF2α-P) were followed by immunoblotting. GAPDH
was used as loading control. (b) Densitometry data represent the intensity of procaspase-3, cleaved PARP normalized for GAPDH, LC3II
normalized for LC3I, ULK-555-P normalized for total level of ULK1, AMPK-P normalized for total level of AMPK, 4-EBP1-P
normalized for total level of 4-EBP1, and eiF2α-P normalized for total level of eiF2α. For each of the experiments, three independent
measurements were carried out. Error bars represent standard deviation, and asterisks indicate statistically signiﬁcant diﬀerence from the
control: ∗p < 0 05; ∗∗p < 0 01.
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treatment (Figures 1(b) and S1), indicative of its important
role in green tea polyphenol-induced cell survival.
Previously, we have shown that mTOR is downregulated
with response to ER stress via GADD34 [37]. We have
recently conﬁrmed that blocking GADD34 results in a quick
activation of both mTOR pathway and apoptotic cell death;
meanwhile, AMPK gets downregulated and the period of
autophagy-dependent survival is much shorter upon ER
stress [37]. We also supposed that the negative eﬀect of
GADD34 depletion is successfully suppressed with mTOR
inhibitors and/or AMPK activators (such as rapamycin and
resveratrol) during ER stress [37]. To further conﬁrm the role
of EGCG in unbalancing mTOR-AMPK pathways, a phar-
macological inhibitor (GB) or an siRNA was used to block
GADD34 and then cells were pretreated with EGCG followed
by addition of an ER stressor. In this study, we show that
a 24-hour long pretreatment with a low concentration of
green tea polyphenol followed by TG or TM addition
was able to extend cell viability via intensive activation
of both AMPK and autophagy; meanwhile, mTOR and
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Figure 7: EGCG-dependent eﬀect on mTOR-AMPK pathways rescues GADD34 inhibition with respect to TM-induced ER stress. HEK293T
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ER stressor-induced apoptotic cell death were downregulated
(Figures 6, 7, and 8). Here, we suggest that EGCG treatment
successfully modiﬁes the balance of mTOR-AMPK pathways
and thus the negative eﬀect of GADD34 depletion was
eﬀectively suppressed. These results further conﬁrm that
EGCG-dependent ﬁne-tuning of mTOR-APMK pathways
has a crucial eﬀect to maintain the precise balance of life-
and-death decision under ER stress.
Since the eﬀect of EGCG on mTOR pathway seems to be
contradictory in the literature, EGCG treatment was com-
bined with either mTOR-dependent (rapamycin) or PKA-
dependent (H-89) autophagy promoter to identify which
pathway is involved in autophagy induction in case of EGCG
addition (Figure 2). Autophagy got similarly enhanced both
in EGCG and EGCG+Rap treatments revealing that EGCG
and Rap regulate the self-eating process via the same mTOR
pathway. However, EGCG combined with H-89 signiﬁcantly
promoted autophagy compared to simple H-89 treatment
(Figure 2), suggesting that EGCG-induced autophagy is
not PKA-dependent. Similarly to rapamycin treatment,
transfection with siULK drastically inhibited autophagy
during EGCG treatment (Figure 3) conﬁrming that green
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Figure 8: EGCG-dependent eﬀect on mTOR-AMPK pathways rescues GADD34 depletion with respect to ER stress. GADD34 was silenced
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tea polyphenol induces the self-eating process through
ULK1-AMPK-mTOR regulatory network. Since AMPK
downregulates mTOR pathway via direct phosphorylation,
we cannot rule out that EGCG has both direct and indirect
(through AMPK) negative eﬀects on mTOR. Therefore, fur-
ther studies are needed to identify the exact targets of EGCG.
In conclusion, the positive eﬀects with pretreatment of
precisely chosen concentration of EGCG in a human cell line
are achieved via promoting autophagy-dependent survival.
Therefore, green tea consumption or use of EGCG-loaded
nanoparticles or capsules might have therapeutic role in the
near future not only in the amelioration of the patients’
symptoms suﬀering from ER stress-related diseases, and
in the regulation of body weight as caloric restriction
mimetic, but also—obviously not independently from the
former eﬀects—to expand lifespan of people. Our interest-
ing ﬁndings highlight the potential of EGCG to extend life
expectancy by unbalancing mTOR-AMPK pathways via
GADD34 upon ER stress.
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